Related Experiment Video
Updated: Jun 27, 2026
09:57
Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
Published on: January 20, 2022
Transcatheter Tricuspid Valve Replacement: Current Options and Future Perspectives
Guido Del Monaco1,2, Gianluca Mincione1,2, Alessandro Sticchi3,4
1Cardiovascular Department IRCCS (Istituto di Ricerca e Cura a Carattere Scientifico) Humanitas Research Hospital, 20089 Rozzano, Milan, Italy.
Reviews in Cardiovascular Medicine
|January 27, 2025
Summary
Transcatheter tricuspid valve replacement (TTVR) offers a new option for severe tricuspid regurgitation (TR) patients unsuitable for surgery. While promising, long-term risks like valve thrombosis and pacemaker needs require further study.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Tricuspid regurgitation (TR) is a serious condition with limited treatment options.
- Traditional medical and surgical management poses challenges, especially for high-risk patients.
- Transcatheter therapies are evolving for structural heart disease.
Purpose of the Study:
- To evaluate transcatheter tricuspid valve replacement (TTVR) as an emerging treatment for severe TR.
- To highlight the potential benefits of TTVR in patients with prohibitive surgical risk.
- To identify and discuss the emerging challenges associated with TTVR.
Main Methods:
- Review of current clinical data and emerging evidence on TTVR procedures.
- Analysis of patient populations benefiting from transcatheter interventions.
- Identification of key areas for future research and clinical monitoring.
Main Results:
- TTVR shows positive clinical outcomes across diverse anatomies and patient groups.
- Transcatheter approach provides an alternative for patients with high surgical risk.
- Emerging concerns include long-term valve durability, thrombosis risk, and pacemaker implantation rates.
Conclusions:
- TTVR is a viable and evolving therapeutic option for severe TR.
- Further investigation into long-term safety and efficacy is crucial.
- Addressing challenges like valve durability and procedural complications will enhance TTVR adoption.
More Related Videos
Related Concept Videos
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...